Skip to main content

Breast Implants Market 2021-2028 Size, Share, Growth Factors, Trends, Revenue, Competitive Landscape, Forecast Report by Fortune Business Insights

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Companies in Breast Implants Market are Sientra, Inc. (California, U.S.) , GC Aesthetics (Dublin, Ireland) , POLYTECH Health & Aesthetics GmbH (Dieburg, Germany) , AbbVie Inc. (Illinois, U.S.) , Mentor Worldwide LLC (California, U.S.) , CEREPLAS (Cambrai, France) , Establishment Labs S.A. (Alajuela, Costa Rica) , LABORATOIRES ARION (Sophia Antipolis, France) , Other Players

Pune, India, Nov. 22, 2021 (GLOBE NEWSWIRE) — The global breast implants market size is projected to reach USD 3.05 billion by the end of 2027. The increasing adoption of visually appealing lifestyle habits will create several growth opportunities for the companies operating in the market. Recent advancements in surgical procedures have reduced the adverse effects and subsequently aid the growth of the overall market in the coming years.

According to a report published by Fortune Business Insights, titled “Breast Implants Market Size, Share & COVID-19 Impact Analysis, By Product (Breast Implants and Tissue Expanders), By Material (Silicone and Saline), By Procedure (Breast Augmentation and Breast Reconstruction) By End User (Hospitals and Specialty Clinics), and Regional Forecast, 2020-2027,” the market was worth USD 2.76 billion in 2019 and will exhibit a CAGR of 7.2% during the forecast period, 2020-2027.


Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/breast-implants-market-101404


Innovative Platforms for Surgical Procedures will Provide Impetus to Market Growth

The report encompasses several factors that have contributed to the growth of the overall market in recent years. Among all factors, the increasing number of product launches and the massive investments associated with breast implant surgical procedures have made the highest impact on the growth of the overall market. In June 2019, GC Aesthetics announced the launch of a new solution for breast implants.

The company introduced ‘Eve 4.0,’ a digital consultation solution (DCS) that is used to simplify the surgical procedures associated with breast augmentation. The platform provides a visual aid to the consumers opting for these procedures. The platform was introduced for enhancing surgical procedures for customers in Europe and Brazil. It is observed that such innovative platforms are not a rarity in the global market thanks to the rising technological intervention in almost all parts of the world. GC’s latest surgical implant platform will not just benefit the company but will also emerge in favor of the growth of the overall market in the coming years.


To get to know more about the short-term and long-term impact of COVID-19 on this market,

Please Visit: https://www.fortunebusinessinsights.com/industry-reports/breast-implants-market-101404


North America Likely to Emerge Dominant; Favorable Reimbursement Policies for Breast Reduction will Bode well for Market Growth

The report analyses the latest market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing surgical procedures associated with breast augmentation and implants, especially in the United States will emerge in favor of market growth.

The favorable health reimbursement policies will also contribute to the growth of the regional market. As of 2019, the market in North America was worth 1.09 billion and this value is projected to increase at a considerable pace in the coming years. The market in Asia Pacific will derive growth from the increasing adoption of appealing lifestyle habits and the constantly rising population in countries such as China and India.


List of companies profiled in the report:

  • Sientra, Inc. (California, U.S.)
  • GC Aesthetics (Dublin, Ireland)
  • POLYTECH Health & Aesthetics GmbH (Dieburg, Germany)
  • AbbVie Inc. (Illinois, U.S.)
  • Mentor Worldwide LLC (California, U.S.)
  • CEREPLAS (Cambrai, France)
  • Establishment Labs S.A. (Alajuela, Costa Rica)
  • LABORATOIRES ARION (Sophia Antipolis, France)
  • Other Players


Quick Buy – Breast Implants Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/101404


Industry Developments:

March 2020: AbbVie Inc. announced that it has completed the acquisition of Allergan; a step that will help the company gain access to the Allergan’s exceptional portfolio.


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com


Read Press Release: https://www.fortunebusinessinsights.com/press-release/breast-implants-market-9270

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.